Federal contractor · BRISBANE, CA

CAREDX, INC.

CAREDX, INC. received $3.6M in federal contract obligations in FY2026, on 9 awards (−26% vs FY2025). Since FY2017: $15.9M. Its largest customer was Department of Veterans Affairs ($3.6M).

Obligations · FY2026: $3.6M
New awards: 9
Sole-source: 55%
Single offer: 1.3%

UEI: Y371A27ZEUM4

Small business

Open in the contracts explorer Relationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

806.6KFY2017
-153.6KFY2018
727.7KFY2019
-122KFY2020
604.9KFY2021
1.7MFY2022
2.5MFY2023
1.2MFY2024
4.9MFY2025
3.6MFY2026

Top buying agencies

Obligations in FY2026.

Department of Veterans Affairs$3.6M100%
9 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Health & medical$2M56%
Other equipment & supplies$1.6M44%

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Low competition56%
US 39% · $2M
Sole-source awards55%
US 30% · $2M
Single-offer competitions1.3%
US 8.8% · $48.3K
Urgency justifications0.0%
US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Agencies awarding it sole-source contracts

Department of Veterans Affairs$2M
Department of Veterans Affairs · 3 awards

Largest awards

TRANSPLANT TESTING KITS$1.6M
Department of Veterans Affairs· San Mateo County, CA· Other equipment & supplies· Jan 22, 2026 – Jan 22, 2026· 36C25226N0079
ALLOMAP AND ALLOSURE POST HEART TRANSPLANT REJECTION SURVEILLANCE TESTS SERVICES$1.3M
Department of Veterans Affairs· San Mateo County, CA· Health & medical· Feb 28, 2022 – Jul 28, 2026· 36C26122C0017
GENETIC BLOOD TESTING FOR TRANSPLANT PATIENTS (ALLOMAP AND ALLOSURE)$1M
Department of Veterans Affairs· Rutherford County, TN· Health & medical· Jul 13, 2026 – Jul 21, 2026· 36C24926N0622
LAB TESTS FOR POST TRANSPLANT CARE.$770.8K
Department of Veterans Affairs· Harris County, TX· Health & medical· Feb 6, 2026 – Feb 6, 2026· 36C25626N0370
GENETIC BLOOD TESTING FOR TRANSPLANT PATIENTS (ALLOMAP AND ALLOSURE)$529.9K
Department of Veterans Affairs· Rutherford County, TN· Health & medical· Aug 19, 2024 – Feb 17, 2026· 36C24924N0581
ALLOSURE KIDNEY TEST$170.8K
Department of Veterans Affairs· San Mateo County, CA· Health & medical· Oct 1, 2022 – Jul 1, 2026· 36C24623P0011
LABORATORY SERVICES$170.4K
Department of Veterans Affairs· San Mateo County, CA· Health & medical· Jan 15, 2025 – Apr 14, 2026· 36C26325N0369
ALLOSURE IN-HOME PATIENT TESTING$142K
Department of Veterans Affairs· Johnson County, IA· Health & medical· Nov 18, 2025 – Nov 18, 2025· 36C26326N0261

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 3 markets (agency × industry), FY2024–FY2026.

INNER VISION RADIOLOGY LLC$7.4M−41% in FY2026
OZARK, AR · 75% of this company's obligations are in markets they both serveVeterans Affairs · Medical and diagnostic laboratories
FULGENT THERAPEUTICS LLC$10.5M−123% in FY2026
EL MONTE, CA · 2 entities · 81% of this company's obligations are in markets they both serveVeterans Affairs · Medical and diagnostic laboratoriesVeterans Affairs · Pharmaceutical and medicine manufacturing
NEOGENOMICS LABORATORIES, INC.$7.1M+22% in FY2026
FORT MYERS, FL · 65% of this company's obligations are in markets they both serveVeterans Affairs · Medical and diagnostic laboratoriesVeterans Affairs · Architectural, engineering, and related services

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 3, 2026, loaded Oct 3, 2026 · FY2024–FY2026.

Lobbying and PAC activity

Organizations in House lobbying disclosures and FEC records whose names an AI judgment matched to this company. Those records carry no identifier shared with contracts, so every match is by name.

Matched organizations

CAREDX, INC.AI match · 100%

Lobbying · 2025: $330K; 16 reports
Lobbying · 2023–2026: $1.9M; $430K in its own reports

Lobbying by year

2023$659K
16 reports
2024$723K
20 reports
2025$330K
16 reports
2026$230K
4 reports

Top issues

Health issues45 reports
Medicare and Medicaid12 reports

Who was contacted

U.S. HOUSE OF REPRESENTATIVES33 reports
U.S. SENATE32 reports
Centers For Medicare and Medicaid Services (CMS)23 reports
Health & Human Services - Dept of (HHS)14 reports
Veterans Affairs - Dept of (VA)14 reports

Houses of Congress and federal agencies the reports list as contacted (a report names every one for all its issues).

Lobbying firms hired

Brownstein Hyatt Farber Schreck, LLP$1.1M
11 reports
CURA STRATEGIES$341K
11 reports
Todd Strategy Group$240K
4 reports
ACTUM I, LLC$120K
7 reports
Mr. Matthew R. Simmons$51K
4 reports
NET CENTRIC ALLIANCE LLC$0
9 reports
TGB STRATEGIES LLC$0
6 reports

Registrants who are individuals are counted, not named.

Lobbying amounts are the filers' own good-faith estimates on quarterly LD-2 reports (the law asks for amounts rounded to $10,000; under $5,000 need not be itemized), latest amendment only. When an organization files its own report, it replaces what outside firms report for it that quarter. Matches are by name. Lobbying and political giving are legal and public: they show engagement with government, not influence over any award. Correlation is not influence: these organizations' lobbying and their contracts are shown side by side, and nothing here implies either affected the other.

Source: Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives), data current to Oct 5, 2026, loaded Oct 5, 2026 · 2023–2026.

Source: Committees, candidates and committee contributions to candidates (Federal Election Commission), data current to Oct 5, 2026, loaded Oct 5, 2026 · 2026, 2024, 2022.

Matches: AI name judgments (entity-match@1, jev-1.13.0), updated Sep 30, 2026.

Congress: members and bills

Through the organizations matched to this company: members of Congress whose campaigns received contributions from their PACs, and the bills their lobbying reports named. Shown beside the company's contracts as a comparison, not a cause.

Bills named in its lobbying reports

H.R. 4582 · To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surgery qualifies as a serious health condition.2 reports
119th Congress · Introduced · 2026
H.R. 4583 · Living Donor Protection Act of 20252 reports
119th Congress · Introduced · 2026

8 of 56 reports (2023–2026) name at least one bill. Bills and resolutions the current reports name in their issue descriptions, by number of reports. A report names what it lobbied on, not which side it took.

Amounts, members and bills are as recorded, shown side by side. They say nothing about why a contribution was made, how a member voted or what a report sought. A bill number written in a report is read as the measure of the Congress its context points to (a law's number, the Congress written next to it, the title), else of the Congress then sitting.

Source: Committees, candidates and committee contributions to candidates (Federal Election Commission), data current to Oct 5, 2026, loaded Oct 5, 2026.

Source: Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives), data current to Oct 5, 2026, loaded Oct 5, 2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 3, 2026, loaded Oct 3, 2026.